Inactive Instrument
NovImmune SA Stock
Stocks
IPO-NOVI
CH0010924170
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Nicolas Fischer
CEO | Chief Executive Officer | - | 2019-06-30 |
Nathalie Muller
ADM | Chief Administrative Officer | - | 1999-12-31 |
Hartmut Wekerle
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 81 | 2008-01-31 | |
| Director/Board Member | - | - | |
Tuygan Göker
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | +0.12% | +74.37% | +133.31% | 57.73B | |
| -0.93% | -2.54% | +73.64% | +93.71% | 54.69B | |
| -3.71% | -0.35% | -14.61% | -11.19% | 23.75B | |
| -0.05% | +6.49% | +14.05% | +451.36% | 24.18B | |
| -2.70% | +6.30% | +46.83% | -2.70% | 19.82B | |
| +2.95% | +5.04% | +44.15% | -26.66% | 17.14B | |
| +3.58% | +13.78% | +196.41% | +348.55% | 16.75B | |
| -1.81% | +17.84% | +45.86% | - | 15.57B | |
| -0.57% | +2.30% | +20.33% | +187.27% | 13.96B | |
| Average | -0.37% | +5.80% | +55.67% | +146.71% | 27.06B | |
| Weighted average by Cap. | -0.51% | +4.15% | +58.65% | +137.76% |
Employees
-
- Stock Market
- Stocks
- IPO-NOVI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
